.png){kind=icon}
.png){kind=icon}
Return
Initiating foslevodopa infusion in Parkinson disease: a pragmatic study
.png){kind=icon}
PRE
AI
A
R
G
M
F
R
T
P
A
DOI：10.1016/j.parkreldis.2025.108142.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• Initial foslevodopa infusion requires a gradual increase of dosage during the first weeks, when the initial dose is calculated based on published recommendations • Treatment optimization is achieved on average at a median of 12 weeks, but later in patients with higher body mass index. • The equivalent potency of foslevodopa to oral levodopa is reckoned to be 0.57 mg to 1 mg. • The treatment is well tolerated, but neuropsychiatric effects are more common than previously reported.
Journal
P
IF:
3.4
Papers:
7.3K
Citations:
1.3W
Organization
Cited Papers